Elevated NPM1 and FBL expression correlates with prostate cancer aggressiveness and progression. [PDF]
Saffarian S +4 more
europepmc +1 more source
Unraveling the microbial landscape in prostate cancer: pathogenesis to therapy. [PDF]
Du X, Wu J, Xia S, Zheng H, Zhang B.
europepmc +1 more source
Editorial: Novel therapeutics for urological cancers. [PDF]
Tang S, Li B.
europepmc +1 more source
Prognostic value of baseline circulating tumor DNA levels in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. [PDF]
Liao Y, Lin Y, Luo B, Shen J.
europepmc +1 more source
Gut Associated Metabolites Enhance PD-L1 Blockade Efficacy in Prostate Cancer. [PDF]
Liu K +13 more
europepmc +1 more source
First-Line [<sup>177</sup>Lu]Lu-PSMA-617 Therapy Without ADT, Chemotherapy, or Local Therapy for Metastatic Hormone-Sensitive Prostate Cancer. [PDF]
Giri VK, Kolodny GM, Garnick MB.
europepmc +1 more source
Prostatic cancer with parotid metastases. [PDF]
Inrhaoun H +10 more
europepmc +1 more source
Incidentally Detected Ductal Adenocarcinoma Presenting With Isolated Pulmonary Metastasis and a BRCA2 Mutation. [PDF]
Karasawa H +6 more
europepmc +1 more source
Effectiveness and Safety of Radium-223 for Bone-Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study. [PDF]
Shiota M +12 more
europepmc +1 more source
Prevalence and spectrum of homologous recombination repair mutations in patients with metastatic prostate cancer from India. [PDF]
Baskarane H +17 more
europepmc +1 more source

